Medigen Vaccine Biologics Corporation (TPEX: 6547)

Medigen Vaccine Biologics Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 21, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	16,124	23,035	22,785	63,653	21,743	4,447
Market Cap Growth	-37.85%	1.10%	-64.20%	192.75%	388.97%	-18.31%
Enterprise Value	14,655	21,271	20,540	62,660	22,145	4,962
Last Close Price	49.05	70.10	69.50	200.91	69.21	18.76
PE Ratio	-	-	-	45.14	-	-
PS Ratio	24.87	59.12	62.42	19.40	1889.56	3970.30
PB Ratio	4.18	5.99	4.53	13.61	6.92	3.25
P/TBV Ratio	3.88	6.05	4.57	13.77	7.06	3.41
P/FCF Ratio	-	-	-	142.64	-	-
P/OCF Ratio	-	-	-	109.77	-	-
EV/Sales Ratio	22.61	54.59	56.27	19.10	1924.50	4430.19
EV/EBITDA Ratio	-	-	-	58.45	-	-
EV/EBIT Ratio	-	-	-	65.02	-	-
EV/FCF Ratio	-134.07	-	-	140.41	-	-
Debt / Equity Ratio	0.08	0.51	0.39	0.04	0.06	0.58
Debt / EBITDA Ratio	-	-	-	0.17	-	-
Debt / FCF Ratio	-	-	-	0.42	-	-
Asset Turnover	0.12	0.06	0.06	0.75	0.00	0.00
Inventory Turnover	0.32	0.25	0.76	2.84	0.09	-
Quick Ratio	10.16	1.99	12.48	6.54	11.58	2.04
Current Ratio	12.69	2.21	15.38	8.47	12.48	2.28
Return on Equity (ROE)	-15.48%	-26.14%	-30.39%	36.08%	-29.91%	-41.47%
Return on Assets (ROA)	-7.39%	-11.29%	-15.18%	13.71%	-16.55%	-16.92%
Return on Capital (ROIC)	-7.67%	-11.85%	-16.21%	14.71%	-17.38%	-17.55%
Return on Capital Employed (ROCE)	-	-	-	19.83%	-	-
Earnings Yield	-3.97%	-5.04%	-6.47%	2.22%	-3.10%	-13.89%
FCF Yield	-0.68%	-2.24%	-5.94%	0.70%	-3.17%	-10.57%
Buyback Yield / Dilution	-0.21%	-1.50%	-0.73%	-15.82%	-20.08%	-3.64%
Total Shareholder Return	-0.21%	-1.50%	-0.73%	-15.82%	-20.08%	-3.64%

Source: S&P Capital IQ. Standard template. Financial Sources.